query

Healthcare companies are now in the spotlight as the Covid-19 pandemic continues. Listed companies such as Biolidics and Q&M Dental Group have announced their intention to produce Covid-19 test kits. And markets have reacted accordingly.

SINGAPORE (Mar 29): YuuZoo has arrived at an in-principle agreement to resolve SGX’s query of its $8 million of 4Q other income with its auditor, RT LPP.

SINGAPORE (Feb 21): Y Ventures Group has been queried by the Singapore Exchange (SGX) for its “unusual price movements” after shares in the e-commerce company climbed as high as 75 cents on Wednesday morning, up 10.4% from its opening price of 68 cent

SINGAPORE (Sept 28): Mencast says the group is in early stage exploratory discussions with certain parties in relation to transaction which may involve the divestment of assets.

SINGAPORE (March 6): Bukit Sembawang Estates says a DBS Group Research report released last Thursday and subsequently picked up by the media could explain the stock's unusual price movements on Monday.

SINGAPORE (Jan 20): Civmec, the heavy engineering company based in Australia, says its recent share surge could be due to the group’s previously-announced project awards as well as news of its shipbuilding facility expansion plans.

SINGAPORE (Oct 18): ISR Capital surged six cents or more than 23.5% to close at 31.5 cents on Tuesday. This drew a query from the Singapore Exchange at 5.23 pm to explain if the company is aware of reasons behind the unusual trading activity.

SINGAPORE (Oct 11): The Singapore Exchange has queried KrisEnergy over its trading activity, its second time in 30 days, noting the unusual price movement of its shares.

SINGAPORE (Oct 10): Sapphire Corporation says it does not know the reasons behind the unusual price and volume movements of its shares but that it is notholding back any undiclosed information and that it is acting in compliance with listing rules.

SINGAPORE (Oct 10): Shares of Vard jumped as much as 13.9% on Monday, prompting a query from the Singapore Exchange.